Improving Prognostic Tools for Patients With Myelodysplastic Syndromes

Mayo Clinic Proceedings - Netherlands
doi 10.1016/j.mayocp.2018.08.025
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

Myelodysplastic Syndromes: Histopathology as Prognostic Factor

Revista Brasileira de Hematologia e Hemoterapia
2001English

Hematopoietic Stem Cell Transplantation for Older Patients With Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Comparison of Risk Stratification Tools in Predicting Outcomes of Patients With Higher-Risk Myelodysplastic Syndromes Treated With Azanucleosides

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Myelodysplastic Syndromes

Cancer
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy